Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor... 16 KB (1,447 words) - 02:46, 31 March 2024 |
FDA approved, but several compounds are in clinical trials. See also Ribociclib#Mechanism of action re: CDK4 The cell cycle is a highly regulated process... 24 KB (2,633 words) - 00:57, 22 April 2024 |